nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—Oesophageal stenosis—Riluzole—amyotrophic lateral sclerosis	0.0325	0.0325	CcSEcCtD
Cevimeline—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.0181	0.0181	CcSEcCtD
Cevimeline—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0166	CcSEcCtD
Cevimeline—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0162	CcSEcCtD
Cevimeline—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0144	CcSEcCtD
Cevimeline—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Cevimeline—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Cevimeline—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Cevimeline—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Cevimeline—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Cevimeline—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0127	CcSEcCtD
Cevimeline—Yawning—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0125	CcSEcCtD
Cevimeline—Dementia—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0122	CcSEcCtD
Cevimeline—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Cevimeline—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Cevimeline—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Cevimeline—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Cevimeline—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Cevimeline—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Cevimeline—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Cevimeline—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Cevimeline—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Cevimeline—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00996	0.00996	CcSEcCtD
Cevimeline—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00956	0.00956	CcSEcCtD
Cevimeline—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00919	0.00919	CcSEcCtD
Cevimeline—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00907	0.00907	CcSEcCtD
Cevimeline—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00896	0.00896	CcSEcCtD
Cevimeline—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00875	0.00875	CcSEcCtD
Cevimeline—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00864	0.00864	CcSEcCtD
Cevimeline—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00854	0.00854	CcSEcCtD
Cevimeline—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00835	0.00835	CcSEcCtD
Cevimeline—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00817	0.00817	CcSEcCtD
Cevimeline—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00775	0.00775	CcSEcCtD
Cevimeline—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00767	CcSEcCtD
Cevimeline—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00767	CcSEcCtD
Cevimeline—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00737	CcSEcCtD
Cevimeline—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00737	CcSEcCtD
Cevimeline—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00737	CcSEcCtD
Cevimeline—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00723	0.00723	CcSEcCtD
Cevimeline—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00716	0.00716	CcSEcCtD
Cevimeline—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0071	0.0071	CcSEcCtD
Cevimeline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0071	0.0071	CcSEcCtD
Cevimeline—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00703	0.00703	CcSEcCtD
Cevimeline—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00703	0.00703	CcSEcCtD
Cevimeline—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00697	CcSEcCtD
Cevimeline—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00697	CcSEcCtD
Cevimeline—Mania—Riluzole—amyotrophic lateral sclerosis	0.00691	0.00691	CcSEcCtD
Cevimeline—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00679	CcSEcCtD
Cevimeline—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00667	0.00667	CcSEcCtD
Cevimeline—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00656	0.00656	CcSEcCtD
Cevimeline—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00645	0.00645	CcSEcCtD
Cevimeline—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00635	0.00635	CcSEcCtD
Cevimeline—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00625	CcSEcCtD
Cevimeline—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0062	CcSEcCtD
Cevimeline—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00606	0.00606	CcSEcCtD
Cevimeline—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00593	0.00593	CcSEcCtD
Cevimeline—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00584	CcSEcCtD
Cevimeline—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00576	CcSEcCtD
Cevimeline—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00572	CcSEcCtD
Cevimeline—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00556	CcSEcCtD
Cevimeline—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00552	CcSEcCtD
Cevimeline—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00552	CcSEcCtD
Cevimeline—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00549	CcSEcCtD
Cevimeline—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00545	0.00545	CcSEcCtD
Cevimeline—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00542	CcSEcCtD
Cevimeline—Gout—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00538	CcSEcCtD
Cevimeline—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00535	0.00535	CcSEcCtD
Cevimeline—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00531	0.00531	CcSEcCtD
Cevimeline—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00528	CcSEcCtD
Cevimeline—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00515	CcSEcCtD
Cevimeline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00512	CcSEcCtD
Cevimeline—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00502	CcSEcCtD
Cevimeline—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00502	CcSEcCtD
Cevimeline—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00502	CcSEcCtD
Cevimeline—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00497	CcSEcCtD
Cevimeline—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00491	CcSEcCtD
Cevimeline—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00485	0.00485	CcSEcCtD
Cevimeline—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0048	CcSEcCtD
Cevimeline—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00462	CcSEcCtD
Cevimeline—Coma—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00459	CcSEcCtD
Cevimeline—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00454	CcSEcCtD
Cevimeline—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0044	CcSEcCtD
Cevimeline—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00436	CcSEcCtD
Cevimeline—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00436	CcSEcCtD
Cevimeline—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00427	CcSEcCtD
Cevimeline—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00427	CcSEcCtD
Cevimeline—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00419	CcSEcCtD
Cevimeline—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00419	CcSEcCtD
Cevimeline—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Cevimeline—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Cevimeline—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00406	CcSEcCtD
Cevimeline—Injury—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00397	CcSEcCtD
Cevimeline—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00388	CcSEcCtD
Cevimeline—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00388	CcSEcCtD
Cevimeline—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00383	CcSEcCtD
Cevimeline—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00378	CcSEcCtD
Cevimeline—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00375	CcSEcCtD
Cevimeline—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00366	CcSEcCtD
Cevimeline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00365	CcSEcCtD
Cevimeline—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00365	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00365	CcSEcCtD
Cevimeline—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00359	CcSEcCtD
Cevimeline—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00359	CcSEcCtD
Cevimeline—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00352	CcSEcCtD
Cevimeline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00347	CcSEcCtD
Cevimeline—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00345	CcSEcCtD
Cevimeline—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00339	CcSEcCtD
Cevimeline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00333	CcSEcCtD
Cevimeline—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00332	CcSEcCtD
Cevimeline—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00323	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00322	CcSEcCtD
Cevimeline—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00322	CcSEcCtD
Cevimeline—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00317	CcSEcCtD
Cevimeline—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00315	CcSEcCtD
Cevimeline—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00315	CcSEcCtD
Cevimeline—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00307	CcSEcCtD
Cevimeline—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00303	CcSEcCtD
Cevimeline—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00295	CcSEcCtD
Cevimeline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00291	CcSEcCtD
Cevimeline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0029	CcSEcCtD
Cevimeline—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00288	CcSEcCtD
Cevimeline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00287	CcSEcCtD
Cevimeline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00285	CcSEcCtD
Cevimeline—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00283	CcSEcCtD
Cevimeline—Depression—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0028	CcSEcCtD
Cevimeline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00277	CcSEcCtD
Cevimeline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00275	CcSEcCtD
Cevimeline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00275	CcSEcCtD
Cevimeline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00274	CcSEcCtD
Cevimeline—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00273	CcSEcCtD
Cevimeline—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00268	CcSEcCtD
Cevimeline—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00265	CcSEcCtD
Cevimeline—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00264	CcSEcCtD
Cevimeline—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00262	CcSEcCtD
Cevimeline—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00254	CcSEcCtD
Cevimeline—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00253	CcSEcCtD
Cevimeline—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00252	CcSEcCtD
Cevimeline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00251	CcSEcCtD
Cevimeline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00251	CcSEcCtD
Cevimeline—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0025	CcSEcCtD
Cevimeline—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00249	CcSEcCtD
Cevimeline—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00247	CcSEcCtD
Cevimeline—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00236	CcSEcCtD
Cevimeline—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00234	CcSEcCtD
Cevimeline—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00229	CcSEcCtD
Cevimeline—Chills—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00226	CcSEcCtD
Cevimeline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00225	CcSEcCtD
Cevimeline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00223	CcSEcCtD
Cevimeline—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0022	CcSEcCtD
Cevimeline—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00216	CcSEcCtD
Cevimeline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00215	CcSEcCtD
Cevimeline—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00212	CcSEcCtD
Cevimeline—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00211	CcSEcCtD
Cevimeline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00206	CcSEcCtD
Cevimeline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00204	CcSEcCtD
Cevimeline—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00203	CcSEcCtD
Cevimeline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00202	CcSEcCtD
Cevimeline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00198	CcSEcCtD
Cevimeline—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00197	CcSEcCtD
Cevimeline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00197	CcSEcCtD
Cevimeline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00197	CcSEcCtD
Cevimeline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00194	CcSEcCtD
Cevimeline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00193	CcSEcCtD
Cevimeline—Cough—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00192	CcSEcCtD
Cevimeline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0019	CcSEcCtD
Cevimeline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0019	CcSEcCtD
Cevimeline—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00187	CcSEcCtD
Cevimeline—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00187	CcSEcCtD
Cevimeline—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00187	CcSEcCtD
Cevimeline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00186	CcSEcCtD
Cevimeline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00185	CcSEcCtD
Cevimeline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00181	CcSEcCtD
Cevimeline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00179	CcSEcCtD
Cevimeline—Infection—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00178	CcSEcCtD
Cevimeline—Shock—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00176	CcSEcCtD
Cevimeline—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00176	CcSEcCtD
Cevimeline—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00176	CcSEcCtD
Cevimeline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00175	CcSEcCtD
Cevimeline—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00174	CcSEcCtD
Cevimeline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00173	CcSEcCtD
Cevimeline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00171	CcSEcCtD
Cevimeline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00167	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00163	CcSEcCtD
Cevimeline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00162	CcSEcCtD
Cevimeline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00161	CcSEcCtD
Cevimeline—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0016	CcSEcCtD
Cevimeline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00159	CcSEcCtD
Cevimeline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00158	CcSEcCtD
Cevimeline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00156	CcSEcCtD
Cevimeline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00155	CcSEcCtD
Cevimeline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00153	CcSEcCtD
Cevimeline—Pain—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00153	CcSEcCtD
Cevimeline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00148	CcSEcCtD
Cevimeline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00147	CcSEcCtD
Cevimeline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00142	CcSEcCtD
Cevimeline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00142	CcSEcCtD
Cevimeline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00142	CcSEcCtD
Cevimeline—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00132	CcSEcCtD
Cevimeline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00129	CcSEcCtD
Cevimeline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00127	CcSEcCtD
Cevimeline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00123	CcSEcCtD
Cevimeline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00119	CcSEcCtD
Cevimeline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00114	CcSEcCtD
Cevimeline—Rash—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00113	CcSEcCtD
Cevimeline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00113	CcSEcCtD
Cevimeline—Headache—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00112	CcSEcCtD
Cevimeline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00106	CcSEcCtD
